VEGFC and neoplasm: Accordingly, it has been reported that VEGF-C-activated lymphatic endothelial cells in the dLN suppress antitumor immunity by scavenging and cross-presenting tumor antigens, leading to T cell dysfunctional activation and deletion in dLNs [12].